Skip to Content
Søk Menu

Rapport från ISHL-11 i Köln och delvis från ASH i San Diego

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Anna Sureda Balari

Epcoritamab with rituximab and lenalidomide (R2) for patients with high-risk follicular lymphoma

/ Anna Sureda Balari
EHA23Lymfom Play the Video 6:24

Belamaf and dexamethasone – Safe, effective multiple myeloma treatment

/ Evangelos Terpos / Jan Andreasen
EHA23Myelom

Gilteritinib for patients with newly diagnosed AML

/ Mark Levis
EHA23Näring Play the Video 9:04
Arnon Kater

MURANO study supports the use of fixed-duration VenR in R/R CLL

/ Arnon Kater
KLLEHA23 Play the Video 10:51
Evangelos Terpos

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Evangelos Terpos
EHA23Myelom Play the Video 6:39
Eva Futtrup Maksten

Risk of dementia in older patients treated with chemotherapy for lymphoma

/ Eva Futtrup Maksten
DemensEHA23 Play the Video 03:17

UK Trial Gives Voice to CLL Patients’ Experiences with Targeted Therapies

/ Dima El-Sharkawi
KLLEHA23 Play the Video 02:03

Promising Findings for R/R Large B-cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Martin Hutchings
EHA23ASCO23Lymfom Play the Video 04:16

New CLL Study Supports Inclusion of Venetoclax Plus Obinutuzumab in Treatment Guidelines

/ Othman Al-sawaf
KLLEHA23 Play the Video 05:03
Back to top